Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics announced the grant of inducement stock options covering 179,750 shares to eighteen new non-executive employees on September 17, 2026. The options have an exercise price of $10.02 and vest over three years under the company's Amended and Restated 2021 Inducement Plan.